Pregnancy Outcomes in Patients With Adult Congenital Heart Disease
Pregnancy Outcomes in Patients With Adult Congenital Heart Disease
The purpose of this study is to determine if a biomarker assay obtained peripartum (1st-3rd trimester and post-partum) in patients with adult congenital heart disease can predict future risk of cardiovascular adverse events and determine if temporal changes in biomarkers levels throughout the peripartum period can provide a better risk prediction compared to samples taken at a single time-point.
Inclusion Criteria:
Exclusion Criteria: